Hillman Bruce J, Black William C, D'orsi Carl, Hauser J Bruce, Smith Robert
Department of Radiology, University of Virginia, Charlottesville, Virginia 22908, USA.
J Am Coll Radiol. 2004 Nov;1(11):861-4. doi: 10.1016/j.jacr.2004.05.019.
Screening for disease using imaging technologies is a growing phenomenon. For some applications (e.g., mammography and breast cancer), there is solid evidence that imaging screening reduces disease-specific mortality. However, for other applications, the public interest in imaging screening is progressing despite a lack of valid scientific evidence that such screening improves the public's health. Clinical trials promise to eventually shed light on the value of imaging screening, but the results of these trials will not be known for several years. In the meantime, physicians and the public need guidance on whether specific imaging screening examinations are appropriate. The ACR charged the Methods Committee of its Task Force on Screening Technologies to advise the organization on how it could best use available evidence to make public recommendations on imaging screening technologies. This article is the outcome of the committee's deliberations, including recommendations for the method of arriving at a recommendation, the approach to dissemination, and to whom the recommendations should be targeted.
使用成像技术进行疾病筛查是一个日益普遍的现象。对于某些应用（如乳腺X线摄影和乳腺癌），有确凿证据表明成像筛查可降低特定疾病的死亡率。然而，对于其他应用，尽管缺乏有效科学证据证明此类筛查能改善公众健康，但公众对成像筛查的兴趣仍在增加。临床试验有望最终揭示成像筛查的价值，但这些试验结果在数年内都不会知晓。在此期间，医生和公众需要关于特定成像筛查检查是否合适的指导。美国放射学会责成其筛查技术特别工作组的方法委员会就如何最好地利用现有证据向该组织提供关于成像筛查技术的公开建议。本文是委员会审议的结果，包括对得出建议的方法、传播途径以及建议应针对的对象的建议。
